Literature DB >> 21612407

Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2.

JiHye Kim1, Jung-A Pyun, Sung Won Cho, KwangJae Lee, KyuBum Kwack.   

Abstract

Poly (ADP-ribose) polymerase 1 (PARP1), which plays a critical role in the base excision DNA repair mechanism, and matrix metallopeptidase 2 (MMP2), a member of the matrix metalloprotease family, are involved in tumor formation and metastasis, respectively. In the present study, the possible association of single nucleotide polymorphisms (SNPs) and gene-gene interaction between PARP1 and MMP2 with the increased incidence of gastric cancer (GC) development and lymph node metastasis (LNM) was investigated in a Korean population. Samples were obtained from 326 patients with chronic gastritis and 153 patients with GC and genotyped using the GoldenGate® method. The PARP1 rs1136410 genotype showed a significant association with the frequency of LNM of GC (odds ratio [OR] = 2.19, p = 0.02), LNM stage (p = 0.035), and tumor invasion (p = 0.035). The allele frequency of MMP2 rs243865 was not associated with the development of GC or with the development of LNM of GC. Epistasis between the PARP1 SNP and the MMP2 SNP was associated with the development of LNM of GC. The combination of the MMP2 rs243865 CC genotype and the PARP1 rs1136410 CC or CC+CT genotypes showed a high risk of LNM of GC (OR = 2.47, p = 0.01; OR = 2.28, p = 0.01, respectively). In summary, PARP1 is associated with the risk of LNM of GC and the stage of LNM and tumor invasion. Epistasis between PARP1 rs1136410 and MMP2 rs243865 increased the risk of LNM of GC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21612407     DOI: 10.1089/dna.2011.1250

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  14 in total

Review 1.  Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.

Authors:  Xiaoying Li; Lianxi Qu; Yu Zhong; Yingjie Zhao; Hongyan Chen; Lu Daru
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-05       Impact factor: 4.553

2.  Potential role of HGF-PARP-1 signaling in invasion of ovarian cancer cells.

Authors:  Wei Wei; Shuqing Lv; Cancan Zhang; Yongjie Tian
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

Review 3.  The PARP Enzyme Family and the Hallmarks of Cancer Part 2: Hallmarks Related to Cancer Host Interactions.

Authors:  Máté A Demény; László Virág
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

4.  PARP1 rs1136410 Val762Ala contributes to an increased risk of overall cancer in the East Asian population: a meta-analysis.

Authors:  Yijuan Xin; Liu Yang; Mingquan Su; Xiaoli Cheng; Lin Zhu; Jiayun Liu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Expression of cluster of differentiation-95 and relevant signaling molecules in liver cancer.

Authors:  Xuming Wang; Kanglai Wei; Qiongguang Zhang; Sien Zeng; Jing Lin; Li Qiao; Lijiang Liu
Journal:  Mol Med Rep       Date:  2014-12-22       Impact factor: 2.952

6.  Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis.

Authors:  Zesheng Wu; Peng Jiang; Haider Zulqarnain; Hua Gao; Wenbin Zhang
Journal:  Onco Targets Ther       Date:  2015-04-16       Impact factor: 4.147

7.  Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies.

Authors:  Rui-Xi Hua; He-Ping Li; Yan-Bing Liang; Jin-Hong Zhu; Bing Zhang; Sheng Ye; Qiang-Sheng Dai; Shi-Qiu Xiong; Yong Gu; Xiang-Zhou Sun
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

8.  High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer.

Authors:  Ying Liu; Yu Zhang; Ying Zhao; Dongna Gao; Jing Xing; Hui Liu
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

9.  The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis.

Authors:  Ziheng Peng; Jinhai Jia; Wenjian Gong; Xuehan Gao; Peiru Ma; Zhucheng Jin; Yue Fan; Yanchu Li; Xiaolin Zhang
Journal:  Oncotarget       Date:  2017-09-15

10.  PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer.

Authors:  Guangying Qi; Yasusei Kudo; Bo Tang; Tian Liu; Shengjian Jin; Jing Liu; Xiaoxu Zuo; Sisi Mi; Wenhuan Shao; Xiaojuan Ma; Takaaki Tsunematsu; Naozumi Ishimaru; Sien Zeng; Masaaki Tatsuka; Fumio Shimamoto
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.